Shoulder Arthroplasty for Shoulder Conditions
Trial Summary
What is the purpose of this trial?
The objectives of this study are to confirm the safety, performance, and clinical benefits of Zimmer Biomet Shoulder Arthroplasty Systems and its instrumentation in primary or revision shoulder arthroplasty. These objectives will be assessed using standard scoring systems, radiographic evidence, and adverse event records. Safety of the system will be assessed by monitoring the frequency an incidence of adverse events.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
What data supports the effectiveness of the Zimmer Biomet Shoulder Arthroplasty Systems treatment?
Research shows that the Zimmer Biomet glenoid vault reconstruction system (VRS) used in reverse shoulder arthroplasty has acceptable short-term outcomes and complication rates. Additionally, the TESS stemless shoulder prosthesis, which is part of the Zimmer Biomet systems, has shown maintained fixation and stability after three years, indicating its effectiveness in shoulder arthroplasty.12345
Is shoulder arthroplasty generally safe for humans?
Research indicates that stemless shoulder arthroplasty systems, like the TESS and other similar implants, have evolved to reduce complications such as osteolysis (bone loss), stress shielding, and periprosthetic fractures (fractures around the implant). These systems are considered safe and effective, with improvements in fixation and stability over time.24567
What makes the Zimmer Biomet Shoulder Arthroplasty Systems treatment unique for shoulder conditions?
The Zimmer Biomet Shoulder Arthroplasty Systems offer a modular design that allows for precise anatomical reconstruction of the shoulder joint, which can be tailored to individual patient needs. This system includes options like the stem-free shoulder, which avoids complications associated with traditional stemmed implants, making it a novel choice compared to standard shoulder arthroplasty treatments.13589
Research Team
Ryan Boylan
Principal Investigator
Zimmer Biomet
Eligibility Criteria
This trial is for adults over 20 with shoulder issues like arthritis, fractures, or deformities who need a shoulder replacement and have a working deltoid muscle. It's not for those with neuromuscular diseases affecting the limb, severe bone conditions, infections near the joint, pregnant or breastfeeding women, vulnerable populations, or anyone unable to follow the study protocol.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Zimmer Biomet Shoulder Arthroplasty System in primary or revision shoulder arthroplasty
Follow-up
Participants are monitored for safety and effectiveness after treatment, including radiographic evaluations and clinical assessments
Long-term Follow-up
Participants are monitored for implant survivorship and adverse events over a long-term period
Treatment Details
Interventions
- Zimmer Biomet Shoulder Arthroplasty Systems
- Zimmer Biomet Shoulder Arthroplasty Systems Instrumentation
Zimmer Biomet Shoulder Arthroplasty Systems is already approved in European Union, United States, Canada for the following indications:
- Osteoarthritis
- Posttraumatic arthrosis
- Focal avascular necrosis of the humeral head
- Previous surgeries of the shoulder that do not compromise the fixation
- Osteoarthritis
- Fracture
- Rotator cuff arthropathy
- Other non-inflammatory shoulder issues
- Osteoarthritis
- Posttraumatic arthrosis
- Focal avascular necrosis of the humeral head
- Previous surgeries of the shoulder that do not compromise the fixation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Zimmer Biomet
Lead Sponsor
Dr. Nitin Goyal
Zimmer Biomet
Chief Medical Officer since 2021
MD from Harvard Medical School
Ivan Tornos
Zimmer Biomet
Chief Executive Officer since 2023
MBA from the University of Miami School of Business, BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business